Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Cholecystitis | Case report

First case report of acute cholangitis secondary to Cronobacter sakazakii

Authors: Syeda Sahra, Abdullah Jahangir, Neville Mobarakai, Allison Glaser, Ahmad Jahangir, Muhammad Ans Sharif

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Introduction

Cronobacter sakazakii is an opportunistic Gram-negative, rod-shaped bacterium which may be a causative agent of meningitis in premature infants and enterocolitis and bacteremia in neonates and adults. While there have been multiple cases of C. sakazakii infections, there have been no acute cholangitis cases reported in humans.

Case presentation

An 81-year-old male with a past medical history of basal cell carcinoma, alcoholic liver cirrhosis, transjugular intrahepatic portosystemic shunt procedure, complicated by staphylococcus bacteremia, pituitary tumor, glaucoma, and hypothyroidism presented to the emergency room with the complaint of diffuse and generalized 10/10 abdominal pain of 1 day’s duration. There was a concern for pancreatitis, acute cholangitis, and possible cholecystitis, and the patient underwent a percutaneous cholecystostomy tube placement. Blood cultures from admission and biliary fluid cultures both grew C. sakazakii. The patient was treated with a carbapenem and clinically improved.

Conclusions

The case study described a patient with multiple medical comorbidities that presented with C. sakazakii bacteremia and cholangitis. While this bacterium has been implicated in other infections, we believe this is the first time the bacteria is being documented to have caused acute cholangitis.
Literature
7.
go back to reference Dennison SK, Morris J. Multiresistant Enterobacter sakazakii wound infection in an adult. Infect Med. 2002;19:533–5. Dennison SK, Morris J. Multiresistant Enterobacter sakazakii wound infection in an adult. Infect Med. 2002;19:533–5.
15.
go back to reference From the Centers for Disease Control and Prevention. Enterobacter sakazakii infections associated with the use of powdered infant formula--Tennessee, 2001. Jama. 2002;287(17):2204–5.CrossRef From the Centers for Disease Control and Prevention. Enterobacter sakazakii infections associated with the use of powdered infant formula--Tennessee, 2001. Jama. 2002;287(17):2204–5.CrossRef
22.
go back to reference Holý O, et al. Molecular characterization of cronobacter sakazakii strains isolated from powdered milk. Foods. 2020;10(1):20.CrossRef Holý O, et al. Molecular characterization of cronobacter sakazakii strains isolated from powdered milk. Foods. 2020;10(1):20.CrossRef
Metadata
Title
First case report of acute cholangitis secondary to Cronobacter sakazakii
Authors
Syeda Sahra
Abdullah Jahangir
Neville Mobarakai
Allison Glaser
Ahmad Jahangir
Muhammad Ans Sharif
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06195-4

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.